Li, Chong
Guangdong Provincial Key Laboratory of New Drug Screening,
China
2025 Rank: 166598
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1241 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 166598 | 190043 |
| Total Cites | 596 | 608 |
| H-index | 11 | 11 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 169 | 169 |
| Number of Single+First+Last Authored Papers | 58 | 58 |
| Total Cites to Single+First+Last Authored Papers | 406 | 412 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 551 | 561 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.08 |
| Self-Citation Percentage |
1.97%
|
|
Li, Chong
Southwest University,
China
2024 Rank: 163719
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1180 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 163719 | 189556 |
| Total Cites | 488 | 502 |
| H-index | 11 | 11 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 170 | 171 |
| Number of Single+First+Last Authored Papers | 47 | 47 |
| Total Cites to Single+First+Last Authored Papers | 358 | 365 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 450 | 460 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
2.79%
|
|
Li, Chong
Southwest University,
China
2023 Rank: 222106
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1739 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 222106 | 256439 |
| Total Cites | 394 | 402 |
| H-index | 9 | 9 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 154 | 159 |
| Number of Single+First+Last Authored Papers | 42 | 42 |
| Total Cites to Single+First+Last Authored Papers | 317 | 322 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 373 | 380 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.06 |
| Self-Citation Percentage |
1.99%
|
|
Li, Chong
Southwest University,
China
2021 Rank: 225770
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Organic Chemistry
Rank in SubField 1: 1777 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 225770 | 235237 |
| Total Cites | 531 | 585 |
| H-index | 12 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 202 | 233 |
| Number of Single+First+Last Authored Papers | 35 | 35 |
| Total Cites to Single+First+Last Authored Papers | 337 | 376 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 478 | 523 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.12 |
| Self-Citation Percentage |
9.23%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.